Literature DB >> 12195120

Interaction between the C(-344)T polymorphism of CYP11B2 and age in the regulation of blood pressure and plasma aldosterone levels: cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study.

Paola Russo1, Alfonso Siani, Antonella Venezia, Roberto Iacone, Ornella Russo, Gianvincenzo Barba, Lanfranco D'Elia, Francesco P Cappuccio, Pasquale Strazzullo.   

Abstract

OBJECTIVE: To study the interaction between the C(-344)T polymorphism and known determinants (age, body mass and dietary sodium) of blood pressure and plasma aldosterone.
DESIGN: Cross-sectional and longitudinal (1980-1995) survey of male workers in southern Italy.
SETTING: Medical centre of the Olivetti factories. PARTICIPANTS: In 1995, the C(-344)T polymorphism was characterized in 811 untreated men. A subgroup of 280 participants already seen in 1980 was the object of longitudinal analysis. MAIN OUTCOME MEASURES: Blood pressure, demographic, anthropometric and biochemical variables (serum and urinary electrolytes and plasma aldosterone) and frequency of the C(-344)T polymorphism.
RESULTS: In the whole population, there was no difference among genotypes for any of the variables examined. However, multiple regression showed a significant interaction between age (but not body mass or sodium intake) and genotype with regard to systolic (P = 0.03) and diastolic ( P= 0.02) pressure variability independently of covariates. Diastolic pressure increased linearly with age in carriers of the T allele (TT, P<0.001 and TC, P= 0.005), but not in CC homozygotes ( P= 0.848). In T carriers - but not in CC homozygotes - blood pressure and serum potassium increased and plasma aldosterone and serum sodium decreased across quintiles of age (P< 0.001 for all trends). In the longitudinal study, diastolic pressure increased significantly over time only in T carriers (TC+TT: +2.6 +/- 0.6, versus CC: -0.4 +/- 1.5 mmHg, P= 0.04).
CONCLUSION: Inter-individual variation of blood pressure and plasma aldosterone is affected by the interaction of C(-344)T polymorphism and ageing, thus supporting a role for this variant in mechanisms affecting blood pressure regulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195120     DOI: 10.1097/00004872-200209000-00023

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  12 in total

1.  Interaction between the C(-344)T polymorphism of CYP11B2 and alcohol consumption on the risk of essential hypertension in a Chinese Mongolian population.

Authors:  Xing-Qiang Pan; Yong-Hong Zhang; Yong-Yue Liu; Wei-Jun Tong
Journal:  Eur J Epidemiol       Date:  2010-09-29       Impact factor: 8.082

2.  Selected Abstracts from the XXII National Congress of the Italian Society of Hypertension: 2005 September 27-30, Turin, Italy.

Authors: 
Journal:  High Blood Press Cardiovasc Prev       Date:  2005-09

3.  [The role of aldosterone in hypertension].

Authors:  Oliver Vonend; Ivo Quack; Lars Christian Rump
Journal:  Wien Klin Wochenschr       Date:  2010-02       Impact factor: 1.704

4.  Distribution and phenotypic expression of mineralocorticoid receptor and CYP11B2 T-344C polymorphisms in a Taiwanese hypertensive population.

Authors:  Sung-Kien Sia; Hui-Ling Chiou; Shiuan-Chih Chen; Chin-Feng Tsai; Shun-Fa Yang; Kwo-Chang Ueng
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

5.  Human aldosterone synthase gene polymorphism promotes miRNA binding and regulates gene expression.

Authors:  Shreekrishna Maharjan; Brahmaraju Mopidevi; Meenakshi Kaul Kaw; Nitin Puri; Ashok Kumar
Journal:  Physiol Genomics       Date:  2014-10-28       Impact factor: 3.107

6.  Variable transcriptional regulation of the human aldosterone synthase gene causes salt-dependent high blood pressure in transgenic mice.

Authors:  Brahmaraju Mopidevi; Meenakshi K Kaw; Nitin Puri; Madhusudan Ponnala; Sudhir Jain; Anita Rana; Narsimha R Keetha; Sadik A Khuder; Steven N Fiering; Ashok Kumar
Journal:  Circ Cardiovasc Genet       Date:  2014-12-12

7.  Association of CYP11B2 polymorphisms with metabolic syndrome patients.

Authors:  Young Ree Kim; Sun Hyung Kim; Sung Ha Kang; Hyun Ju Kim; Mi Hee Kong; Seung Ho Hong
Journal:  Biomed Rep       Date:  2014-07-11

8.  Human adipocytes secrete mineralocorticoid-releasing factors.

Authors:  M Ehrhart-Bornstein; V Lamounier-Zepter; A Schraven; J Langenbach; H S Willenberg; A Barthel; H Hauner; S M McCann; W A Scherbaum; S R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

9.  Effects of intron conversion in the human CYP11B2 gene on its transcription and blood pressure regulation in transgenic mice.

Authors:  Brahmaraju Mopidevi; Indu Sivankutty; Shoujin Hao; Nicholas R Ferreri; Ashok Kumar
Journal:  J Biol Chem       Date:  2020-06-15       Impact factor: 5.157

10.  Aldosterone Synthase Gene (CYP11B2) Polymorphism in Korean End-Stage Renal Disease Patients on Hemodialysis.

Authors:  Ji Eun Lee; So Yon Bae; Jeong-Yup Kim; Heui Jung Pyo; Young Joo Kwon
Journal:  Electrolyte Blood Press       Date:  2009-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.